Search for other papers by Magdalena Lech in
Google Scholar
PubMed
Search for other papers by Ruvini Ranasinghe in
Google Scholar
PubMed
Faculty of Life Sciences and Medicine, School of Life Course Sciences, King’s College London, London, UK
Search for other papers by Royce P Vincent in
Google Scholar
PubMed
Search for other papers by David R Taylor in
Google Scholar
PubMed
Search for other papers by Lea Ghataore in
Google Scholar
PubMed
Search for other papers by James Luxton in
Google Scholar
PubMed
Quebec Heart and Lung Institute, Laval University, Quebec, Canada
Search for other papers by Fannie Lajeunesse-Trempe in
Google Scholar
PubMed
Search for other papers by Pia Roser in
Google Scholar
PubMed
Search for other papers by Eftychia E Drakou in
Google Scholar
PubMed
Search for other papers by Ling Ling Chuah in
Google Scholar
PubMed
Barts and the London School of Medicine, Centre for Endocrinology, William Harvey Institute, London, UK
Neuroendocrine Tumour Unit, Royal Free Hospital, London, UK
Search for other papers by Ashley B Grossman in
Google Scholar
PubMed
Search for other papers by Simon J B Aylwin in
Google Scholar
PubMed
Obesity, Type 2 Diabetes and Immunometabolism Research Group, School of Cardiovascular and Metabolic Medicine & Sciences, Faculty of Life Course Sciences, King’s College London, London, UK
Division of Reproductive Health, Warwick Medical School, University of Warwick, Coventry, UK
Search for other papers by Georgios K Dimitriadis in
Google Scholar
PubMed
concentration of TBG increases, fT4 concentration decreases, and as a result, there is less fT4 converted into active fT3 for physiological functioning. Therefore, there is an increased likelihood of reliance on levothyroxine replacement to manage the adverse
Search for other papers by Alessandro Brancatella in
Google Scholar
PubMed
Search for other papers by Claudio Marcocci in
Google Scholar
PubMed
with levothyroxine TSH suppressive therapy consists in the administration of levothyroxine (LT4) in order to reduce serum TSH levels below the normal range, maintaining normal levels of serum free T4 (FT4) and free T3 (FT3). Based on TSH levels
Search for other papers by Maria Stelmachowska-Banaś in
Google Scholar
PubMed
Search for other papers by Izabella Czajka-Oraniec in
Google Scholar
PubMed
-stimulating hormone; fT3, free triiodothyronine; fT4, free thyroxine; GCSs, glucocorticoids; HbA1c, hemoglobin A1c; K, potassium; LH, luteinizing hormone; MRI, magnetic resonance imaging; Na, sodium; P, phosphorus; PTH, parathyroid hormone; SST, short Synacthen test
Search for other papers by Anastasia P Athanasoulia-Kaspar in
Google Scholar
PubMed
Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Ludwig-Maximilians-Universität München, Munich, Germany
Search for other papers by Matthias K Auer in
Google Scholar
PubMed
Search for other papers by Günter K Stalla in
Google Scholar
PubMed
Search for other papers by Mira Jakovcevski in
Google Scholar
PubMed
. Evaluation of pituitary function was based on basal measurements of thyroid-stimulating hormone (TSH), free thyroxine (FT4), free triiodothyronine (FT3), luteinizing hormone (LH), follicle-stimulating hormone (FSH) and total testosterone (in men) or estradiol
Search for other papers by Elin Kahlert in
Google Scholar
PubMed
Endokrinologikum Goettingen, Goettingen, Germany
Search for other papers by Martina Blaschke in
Google Scholar
PubMed
Search for other papers by Knut Brockmann in
Google Scholar
PubMed
Search for other papers by Clemens Freiberg in
Google Scholar
PubMed
Search for other papers by Onno E Janssen in
Google Scholar
PubMed
Search for other papers by Nikolaus Stahnke in
Google Scholar
PubMed
Search for other papers by Domenika Strik in
Google Scholar
PubMed
Search for other papers by Martin Merkel in
Google Scholar
PubMed
Search for other papers by Alexander Mann in
Google Scholar
PubMed
Search for other papers by Klaus-Peter Liesenkötter in
Google Scholar
PubMed
Endokrinologikum Goettingen, Goettingen, Germany
Search for other papers by Heide Siggelkow in
Google Scholar
PubMed
result of a change of residence. Thyroid function was evaluated by measuring thyroid-stimulating hormone (TSH) (mU/L), free thyroid hormone (fT4, pg/mL) and free triiodothyronine (fT3, pg/mL). The antibodies (AB) TPO-AB/MAK-AB (thyroperoxidase
Search for other papers by Min Li in
Google Scholar
PubMed
Search for other papers by Ying Chen in
Google Scholar
PubMed
Search for other papers by Jingjing Jiang in
Google Scholar
PubMed
Search for other papers by Yan Lu in
Google Scholar
PubMed
Search for other papers by Zhiyi Song in
Google Scholar
PubMed
Search for other papers by Shengjie Zhang in
Google Scholar
PubMed
Search for other papers by Chao Sun in
Google Scholar
PubMed
Search for other papers by Hao Ying in
Google Scholar
PubMed
Search for other papers by Xiaofang Fan in
Google Scholar
PubMed
Search for other papers by Yuping Song in
Google Scholar
PubMed
Search for other papers by Jialin Yang in
Google Scholar
PubMed
Search for other papers by Lin Zhao in
Google Scholar
PubMed
correlated with TSH and TC levels ( Fig. 1E and F , P < 0.001). In the multivariate linear regression model, FT3 and AST were positively associated with Nrg4 ( Table 2 ). Figure 1 Correlation of Nrg4 with serum levels of free T4 (A), free T3 (B
Search for other papers by Dirk Weismann in
Google Scholar
PubMed
Search for other papers by Andreas Schneider in
Google Scholar
PubMed
Department of Molecular Surgery and Medicine, Karolinska Institute, Stockholm, Sweden
Search for other papers by Charlotte Höybye in
Google Scholar
PubMed
factor for ODS Liver enzymes, S-creatinine Liver disease, renal failure Random cortisol and ACTH Adrenal insufficiency TSH, fT4, fT3 Hypothyroidism ODS, osmotic demyelination syndrome; SIAD, syndrome of inappropriate
Search for other papers by Dimitra Argyro Vassiliadi in
Google Scholar
PubMed
Search for other papers by Ioannis Ilias in
Google Scholar
PubMed
Search for other papers by Maria Pratikaki in
Google Scholar
PubMed
Search for other papers by Edison Jahaj in
Google Scholar
PubMed
Search for other papers by Alice G Vassiliou in
Google Scholar
PubMed
Search for other papers by Maria Detsika in
Google Scholar
PubMed
Search for other papers by Kleio Ampelakiotou in
Google Scholar
PubMed
Search for other papers by Marina Koulenti in
Google Scholar
PubMed
Search for other papers by Konstantinos N Manolopoulos in
Google Scholar
PubMed
Search for other papers by Stamatis Tsipilis in
Google Scholar
PubMed
Search for other papers by Evdokia Gavrielatou in
Google Scholar
PubMed
Search for other papers by Aristidis Diamantopoulos in
Google Scholar
PubMed
Search for other papers by Alexandros Zacharis in
Google Scholar
PubMed
Search for other papers by Nicolaos Athanasiou in
Google Scholar
PubMed
Search for other papers by Stylianos Orfanos in
Google Scholar
PubMed
Search for other papers by Anastasia Kotanidou in
Google Scholar
PubMed
Search for other papers by Stylianos Tsagarakis in
Google Scholar
PubMed
Search for other papers by Ioanna Dimopoulou in
Google Scholar
PubMed
hormonal tests performed (not all previous studies measured FT4 and T3, or FT3, levels to all subjects), the studied population (critical ill vs non-critically ill subjects), the timing of assessment with regards to the course of the disease. Also
Search for other papers by C Sui in
Google Scholar
PubMed
Search for other papers by Q He in
Google Scholar
PubMed
Search for other papers by R Du in
Google Scholar
PubMed
Search for other papers by D Zhang in
Google Scholar
PubMed
Search for other papers by F Li in
Google Scholar
PubMed
Search for other papers by G Dionigi in
Google Scholar
PubMed
Search for other papers by N Liang in
Google Scholar
PubMed
Search for other papers by H Sun in
Google Scholar
PubMed
), and free thyroxine-3 (fT3) tests and neck ultrasonography ( 2 ). Fine-needle aspiration biopsy (FNAB) and preoperative CT were not routinely employed. All patients after surgical treatment required L-tyrosine supplementation ( 2 ). The follow‐up period
Department of Oncology, Comprehensive Cancer Centre, Helsinki University Hospital, Helsinki, Finland
Search for other papers by Hanna Karhapää in
Google Scholar
PubMed
Department of Oncology, Comprehensive Cancer Centre, Helsinki University Hospital, Helsinki, Finland
Search for other papers by Siru Mäkelä in
Google Scholar
PubMed
Department of Radiology, HUS Medical Imaging Centre, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
Search for other papers by Hanna Laurén in
Google Scholar
PubMed
Department of Radiology, HUS Medical Imaging Centre, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
Search for other papers by Marjut Jaakkola in
Google Scholar
PubMed
Endocrinology, Abdominal Centre, University of Helsinki and HUS, Helsinki, Finland
Search for other papers by Camilla Schalin-Jäntti in
Google Scholar
PubMed
Department of Oncology, Comprehensive Cancer Centre, Helsinki University Hospital, Helsinki, Finland
Search for other papers by Micaela Hernberg in
Google Scholar
PubMed
thyroid-stimulating hormone (TSH), free thyroxine (fT4), free triiodothyronine (fT3), and thyroid antibodies: TSH receptor antibodies (TSHRAb), thyroid peroxidase antibodies (TPOAb), and antithyroglobulin antibodies. Before treatment initiation, we also